Mechanisms Inactivating Tumor Suppressor Genes in Cancer

Tumor suppressor genes normally prevent uncontrolled cell growth. Their inactivation is a critical step in cancer development. The events leading to this inactivation are explored below:

Correct Mechanisms of Inactivation

• Promoter Methylation: This epigenetic mechanism involves adding a methyl group to DNA, typically at CpG sites within the gene's promoter region. This modification leads to chromatin condensation, making the DNA inaccessible to transcription factors and effectively silencing the tumor suppressor gene.
• Loss of Heterozygosity (LOH): Many tumor suppressor genes require both alleles to be inactivated for function loss (Knudson's two-hit hypothesis). LOH occurs when the remaining functional copy of the gene is lost or mutated due to events like chromosomal deletion, deletion of the chromosome segment, or mitotic recombination, thereby eliminating the gene's protective function.

Incorrect Mechanisms

• Gene Amplification: This process involves increasing the copy number of a gene. It typically leads to the *overexpression* of genes, commonly *oncogenes*, driving cell proliferation rather than inactivating tumor suppressor genes.
• Histone Acetylation: Generally, histone acetylation relaxes chromatin structure, promoting gene transcription. While changes in histone modifications (like deacetylation) can contribute to gene silencing, histone *acetylation* itself is associated with gene activation, not inactivation of tumor suppressor genes.

Therefore, promoter methylation and loss of heterozygosity are the key events among the options that directly lead to the inactivation of tumor suppressor genes in cancer cells.